News Focus
News Focus
icon url

DewDiligence

07/29/13 12:15 PM

#164625 RE: DewDiligence #164376

HTBX is down 9% from its recent IPO price, a rarity in this biotech market.
icon url

DewDiligence

08/13/13 12:17 PM

#165272 RE: DewDiligence #164376

Bearish sign for HTBX—underwriters exercised only 27% (100K/375K) of the 30-day overallotment option; these options are almost always exercise in full:

http://finance.yahoo.com/news/heat-biologics-inc-announces-partial-154353673.html